BEIJING--(BUSINESS WIRE)--Novo Holdings, a leading global life science investor, and KKR, a leading global investment firm, today announced the signing of definitive agreements under which Novo ...

TITLE: Severe Alopecia, Dermatitis and Acute Interstitial Nephritis Following Oral Semaglutide (Rybelsus) That Is Amenable to Drug-Discontinuation and 6-Weeks of Prednisone—Rybelsus Interstitial ...

TITLE: Severe Alopecia, Dermatitis and Acute Interstitial Nephritis Following Oral Semaglutide (Rybelsus) That Is Amenable to Drug-Discontinuation and 6-Weeks of Prednisone—Rybelsus Interstitial ...

Novo Nordisk became Europe’s most valuable company in 2023 as demand skyrocketed for its weight-loss drugs, Ozempic and Wegovy. However, it's "losing its grip on the anti-obesity market" due to ...

Federal regulations allow compounded versions to be sold to meet demand if a drug ... fee request. "Novo was not aware of any instances of patient harm caused by Brooksville’s semaglutide ...

Liraglutide (Saxenda; Novo Nordisk), semaglutide (Wegovy; Novo Nordisk), and tirzepatide (Zepbound; Lilly) are FDA-approved weight loss GLP-1 RAs that have demonstrated significant benefits.

Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing ...

In addition, the 20% reduced risk for MACE seen in the SELECT trial of semaglutide (Wegovy, Novo Nordisk ... anxiety and substance use disorders in real-world analyses, Drucker said.

So, the semaglutide ... why I continue to cover Novo Nordisk with a "Strong Buy" rating despite the increased competition from Eli Lilly and Trump's attempts to lower drug prices.